Publication | Closed Access

Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. a randomized, placebo-controlled, double-blind study (RUSSLAN)

Heart FailureCardiogenic ShockCardiovascular DiseaseMedicineCardiovascular PharmacologyPharmacotherapyNovel Calcium SensitizerPharmacologyCardiologyLeft Ventricular FailureAcute Myocardial InfarctionMyocardial Infarction